Malignant Glomus Tumour (Glomangiosarcoma) with Additional Neuroendocrine Differentiation in a Horse

Peters, Martin C.; Grafen, J.; Kühnen, C.; Wohlsein, P.

doi:10.1016/j.jcpa.2016.03.002

Cited by 4 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To the best of our knowledge, glomangiosarcoma in the nasal cavity was never reported in humans. The only reported case of glomangiosarcoma in the nasal cavity was in a horse [ 7 ].…”

Section: Discussionmentioning

confidence: 99%

A case of malignant glomus tumor (glomangiosarcoma) of the nasal cavity

Alhroub¹,

Mahameed²,

Abdelhafez³

et al. 2022

Journal of Surgical Case Reports

View full text Add to dashboard Cite

Glomus tumors are rare and usually benign. The malignant form (glomangiosarcoma) comprises <1% of all glomus tumors. There are limited reports that describe glomus tumors in the nasal cavity. However, to the best of our knowledge, glomangiosarcoma of the nasal cavity was never reported in humans. We report on the first case of nasal cavity glomangiosarcoma in a 59-year-old male who presented with a bleeding mass in his right nostril. We completely excised the lesion with a 0.7-mm free margin, and the histopathologic examination was consistent with glomangiosarcoma. A 6-month follow-up illustrated no evidence of recurrence or distant metastasis. Although it is rare, glomus tumors should be in the differential diagnosis of nasal cavity tumors. Histopathologic examination is essential for glomangiosarcoma diagnosis. Treatment requires complete excision with free margin, alongside careful clinical and radiological follow-up.

show abstract

“…To the best of our knowledge, glomangiosarcoma in the nasal cavity was never reported in humans. The only reported case of glomangiosarcoma in the nasal cavity was in a horse [ 7 ].…”

Section: Discussionmentioning

confidence: 99%